首页> 外文期刊>Journal of health, population, and nutrition >Age-sex disparities and sub-clinical hypothyroidism among patients in Tikur Anbesa Specialized Hospital, Addis Ababa, Ethiopia
【24h】

Age-sex disparities and sub-clinical hypothyroidism among patients in Tikur Anbesa Specialized Hospital, Addis Ababa, Ethiopia

机译:埃塞俄比亚亚的斯亚贝巴的提库尔·安贝萨专科医院的患者年龄性别差异和亚临床甲状腺功能减退

获取原文
           

摘要

Background Subclinical hypothyroidism is an elevation in serum thyroid-stimulating hormone above the upper limit of the reference range (0.45–4.5?mIU/L) with normal serum TT4 and TT3 concentration. The most important implication of subclinical hypothyroidism is high likelihood of progression of clinical hypothyroidism. Methods Institution-based cross-sectional study was conducted on medical records of patients referred at endocrine clinic Tikur Anbesa Specialized Hospital, Addis Ababa from 2010 to 2016. This study was conducted from normal ambulatory patients who have come in the hospital outpatient department since they experienced abnormality on their health status. During the study period, patients were complaining about their clinical symptoms. A total number of 9000 patients were included. Patients’ card was retrieved by using standard extracted formats to collect socio-demographic and clinical information and laboratory measurements. Serum TSH, TT4, and TT3 levels were determined by electro-chemiluminescence immunoassay method on ECLIA 2010 fully automatic analyzer at TASH nuclear medicine. SPSS 20 version software was used for analysis, and chi-square test was used to check the association between dependent and independent variables. Results The overall prevalence of subclinical hypothyroidism evaluated to be 582 (6.47%), 4.6% in females and 1.9% in males. Four hundred and thirty-one (74%) patients had serum TSH levels between 5 and 10?mIU/L, and the average TSH level of subclinical hypothyroid patients whose age was ≥?40 differ significantly from that of subclinical hypothyroid patients whose age was
机译:背景亚临床甲状腺功能减退症是指血清TT4和TT3浓度正常时,血清促甲状腺激素升高到参考范围上限(0.45-4.5?mIU / L)以上。亚临床甲状腺功能减退症最重要的含义是临床甲状腺功能减退症发展的可能性很高。方法对2010年至2016年在亚的斯亚贝巴的蒂库尔·安贝萨专科医院内分泌科转诊的患者的病历进行基于机构的横断面研究。这项研究是针对自门诊就诊以来进入医院门诊的正常门诊患者他们的健康状况异常。在研究期间,患者抱怨其临床症状。总共包括9000名患者。通过使用标准提取格式收集社会人口统计学和临床​​信息以及实验室测量值,检索患者的病历卡。在TASH核医学中心使用ECLIA 2010全自动分析仪通过电化学发光免疫分析法测定血清TSH,TT4和TT3水平。使用SPSS 20版本软件进行分析,并使用卡方检验检查因变量和自变量之间的关联。结果亚临床甲状腺功能减退症的总体患病率为582(6.47%),女性为4.6%,男性为1.9%。 413名(74%)患者的血清TSH水平在5至10?mIU / L之间,并且年龄≥40岁的亚临床甲状腺功能减退患者的平均TSH水平与年龄在40岁以上的亚临床甲状腺功能减退患者的平均TSH水平显着不同。 <?40。年龄≥40岁的女性患者中的平均TSH水平与同龄人明显不同。亚临床甲状腺功能减退症患者更经常报告皮肤干燥,记忆力差,疲劳,不耐寒,便秘和声音嘶哑。结论ScHt总体患病率为6.5%,其中女性水平高于男性。 ≥40岁成为亚临床甲状腺功能减退症的独立因素。本研究中亚临床甲状腺功能减退症的较高患病率可能成为明显甲状腺功能减退症的预测指标,因此筛查亚临床甲状腺功能减退症可防止复杂的明显甲状腺功能减退症的后期发展。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号